Evidence map›Paper›PMID 42256550›Full record

ArticleHemaSphere2026

An EHA strategic roadmap for improved care in Europe for AYA patients with malignant and chronic non-malignant hematological diseases.

Anna Castleton, Sally Batten, Nicolas Boissel, Yunus Borowczak, Raffaella Colombatti, Robin Doeswijk, Inken Hilgendorf, Charles McGrath, Kim Messelink, Maurizio Miano and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna CastletonThe Christie NHS Foundation Trust Manchester UK.
Sally BattenEuropean Hematology Association (EHA) The Hague The Netherlands.
Nicolas BoisselAssistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis Paris France.
Yunus BorowczakCML Advocates Network Bern Switzerland.
Raffaella ColombattiDepartment of Women's and Child's Health University of Padova Padova Italy.
Robin DoeswijkEuropean Hematology Association (EHA) The Hague The Netherlands.
Inken HilgendorfUniversitätsklinikum Jena Jena Germany.
Charles McGrathAcute Leukemia Advocates Network Bern Switzerland.
Kim MesselinkRadboud University Medical Center Nijmegen The Netherlands.
Maurizio MianoHaematology Unit IRCCS Istituto Giannina Gaslini Genova Italy.ORCID https://orcid.org/0000-0002-9816-1704
Joanne YacobovichSchneider Children's Medical Center of Israel & Gray's Faculty of Medicine Tel Aviv University Tel Aviv Israel.
H Josef VormoorPrinses Máxima Centrum for Pediatric Oncology & Utrecht University Medical Center Utrecht The Netherlands.ORCID https://orcid.org/0000-0002-1825-1890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42256550
PMCPMC13239201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.